Transporter-mediated Bioavailability

Transporter-Mediated Bioavailability is a pharmacokinetic determinant that quantifies the extent and rate at which a drug, subject to active transport by membrane transporters, reaches systemic circulation in a functionally available form, thereby distinguishing it from passive diffusion-driven bioavailability.

5

Publications

272

Citations

30

Authors

20

Institutions

Publications per year

2017–2026

2

Authors

30

  1. KR
    Klaus‐Dieter Riedel

    Heidelberg University, Germany

    1 publications · 95 citations

    1

    h-index

  2. RL
    Róbert Langer

    Massachusetts Institute of Technology, United States

    1 publications · 66 citations

    1

    h-index

  3. CW
    Christine Wegler

    Uppsala University, Sweden

    1 publications · 82 citations

    1

    h-index

  4. GM
    Gerd Mikus

    Heidelberg University, Germany

    1 publications · 95 citations

    1

    h-index

  5. LZ
    Libo Zhao

    Peking University, China

    1 publications · 17 citations

    1

    h-index

1–5 of 30

Venues

  1. Scientific Reports

    1 publications · 82 citations

    1

    h-index

  2. Journal of Pharmaceutical Sciences

    1 publications · 66 citations

    1

    h-index

  3. European Journal of Pharmaceutical Sciences

    1 publications · 12 citations

    1

    h-index

  4. International Journal of Nanomedicine

    1 publications · 17 citations

    1

    h-index

  5. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 95 citations

    1

    h-index

1–5